Associations between Alcohol Consumption and HDL Subspecies Defined by ApoC3, ApoE and ApoJ: the Cardiovascular Health Study

HDL Containing Apolipoprotein C-III is Associated with Insulin Sensitivity: a Multi-Center Cohort Study

(2021) Rain Yamamoto et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pharmacological Inhibition of CETP (Cholesteryl Ester Transfer Protein) Increases HDL (High-Density Lipoprotein) That Contains ApoC3 and Other HDL Subspecies Associated With Higher Risk of Coronary Heart Disease

(2021) Jeremy D. Furtado et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies

(2018) Angela M Wood et al.   LANCET

High‐Density Lipoprotein Subspecies Defined by Apolipoprotein C‐III and Subclinical Atherosclerosis Measures: MESA (The Multi‐Ethnic Study of Atherosclerosis)

(2018) Sarah A. Aroner et al.   Journal of the American Heart Association

Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

(2018) Max G Griswold et al.   LANCET

Distinct Proteomic Signatures in 16 HDL (High-Density Lipoprotein) Subspecies

(2018) Jeremy D. Furtado et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Associations of anthropometry and lifestyle factors with HDL subspecies according to apolipoprotein C-III

(2017) Manja Koch et al.   JOURNAL OF LIPID RESEARCH

Moderate alcohol consumption and atherosclerosis

(2017) Yunying Huang et al.   WIENER KLINISCHE WOCHENSCHRIFT

High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts

(2017) Majken K. Jensen et al.   CIRCULATION

Trials and Tribulations of CETP Inhibitors

(2017) Alan R. Tall et al.   CIRCULATION RESEARCH

ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease

(2016) Dimitry A Chistiakov et al.   LABORATORY INVESTIGATION

The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism

(2016) Mengdie Luo et al.   Lipids in Health and Disease

Increased concentration of clusterin/apolipoprotein J (apoJ) in hyperlipemic serum is paradoxically associated with decreased apoJ content in lipoproteins

(2015) Anna Rull et al.   ATHEROSCLEROSIS

Alcohol: A Nutrient with Multiple Salutary Effects

(2015) Henry Pownall et al.   Nutrients

Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease

(2014) Beatriz Talayero et al.   JOURNAL OF LIPID RESEARCH

Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease

(2014) Anders Berg Jørgensen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease

(2013) Meliana Riwanto et al.   CIRCULATION

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

(2012) Benjamin F Voight et al.   LANCET

Apolipoprotein C‐III as a Potential Modulator of the Association Between HDL‐Cholesterol and Incident Coronary Heart Disease

(2012) Majken K. Jensen et al.   Journal of the American Heart Association

Biological activities of HDL subpopulations and their relevance to cardiovascular disease

(2011) Laurent Camont et al.   TRENDS IN MOLECULAR MEDICINE

Low Clusterin Levels in High-Density Lipoprotein Associate With Insulin Resistance, Obesity, and Dyslipoproteinemia

(2010) Andrew N. Hoofnagle et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Serum apolipoprotein C-III in high-density lipoprotein: a key diabetogenic risk factor in Turks

(2009) A. Onat et al.   DIABETIC MEDICINE